Why it matters:
It is important that we don't overuse antibiotics. As antimicrobials underpin routine medical practice, antimicrobial resistance poses a significant threat to public health. This measure shows the use of injectable preparations listed in the infections chapter of the British National Formulary, including antibiotics, antivirals and antifungals. We have excluded colistimethate sodium, as the injection is more commonly inhaled for the treatment of infections in people with cystic fibrosis.
The prescribing of injectable preparations may vary substantially throughout the country depending on the availability of local services such as Antibiotic Outpatient Parenteral Therapy (OPAT), where patients receive injectable antibiotics in their own home. Nevertheless it is important to audit and review the appropriateness of all treatments to support good antimicrobial stewardship.
Please note that this is an experimental measure. We would be grateful for any feedback at [email protected].
Description: Number of prescription items for all injectable medicines in BNF Chapter 5 (infections) excluding colistimethate sodium per 1000 patients
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.